Literature DB >> 26886452

Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.

C Gardiol1, R Voumard2, C Cochet3, S de Vallière4,3.   

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective and safe alternative to inpatient treatment, but no formal OPAT unit existed in Switzerland until recently. In December 2013 an OPAT unit was established at Lausanne University Hospital. We review here the experience of this new OPAT unit after 18 months of activity. Patient characteristics, clinical activities and outcomes were recorded prospectively. Need and acceptance was evaluated as number of OPAT courses administered and number of patients refusing OPAT. Safety and efficacy were evaluated as: (1) adverse events linked to antimicrobials and catheters, (2) re-admission to hospital, (3) rate of treatment failures and (4) mortality. Over 18 months, 179 courses of OPAT were administered. Acceptance was high with only four patients refusing OPAT. Urinary tract infections with resistant bacteria and musculoskeletal infections were the most common diagnoses. Self-administration of antibiotics using elastomeric pumps became rapidly the most frequently used approach. Sixteen patients presented with adverse events linked to antimicrobials and catheters. OPAT-related readmissions occurred in nine patients. The overall cure rate was 94 %. This study shows that OPAT is very well accepted by patients and medical staff, even in a setting which has not used this type of treatment approach until now. Self-administration using elastomeric pumps proved to be particularly useful, safe and efficient. OPAT offers a good alternative to hospitalisation for patients presenting with infections due to resistant bacteria that cannot be treated orally anymore and for difficult to treat infections.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26886452     DOI: 10.1007/s10096-016-2606-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

Review 1.  Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

Authors:  Ann L N Chapman; R Andrew Seaton; Mike A Cooper; Sara Hedderwick; Vicky Goodall; Corienne Reed; Frances Sanderson; Dilip Nathwani
Journal:  J Antimicrob Chemother       Date:  2012-01-31       Impact factor: 5.790

2.  Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.

Authors:  D A Barr; L Semple; R A Seaton
Journal:  Int J Antimicrob Agents       Date:  2012-03-23       Impact factor: 5.283

3.  Outpatient intravenous medications in the management of cystic fibrosis.

Authors:  R W Rucker; G M Harrison
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.

Authors:  Marcos Pajarón; Manuel F Fernández-Miera; Iciar Allende; Ana M Arnaiz; Manuel Gutiérrez-Cuadra; Manuel Cobo-Belaustegui; Carlos Armiñanzas; Jose R de Berrazueta; Maria C Fariñas; Pedro Sanroma
Journal:  Eur J Intern Med       Date:  2015-01-14       Impact factor: 4.487

Review 5.  [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].

Authors:  T Galpérine; F Ader; P Piriou; T Judet; C Perronne; L Bernard
Journal:  Med Mal Infect       Date:  2006-03-31       Impact factor: 2.152

6.  Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.

Authors:  Valérie Zeller; Frédérick Durand; Marie-Dominique Kitzis; Luc Lhotellier; Jean-Marc Ziza; Patrick Mamoudy; Nicole Desplaces
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.

Authors:  Ann L N Chapman; Simon Dixon; Dawn Andrews; Patrick J Lillie; Rohit Bazaz; Julie D Patchett
Journal:  J Antimicrob Chemother       Date:  2009-09-19       Impact factor: 5.790

9.  Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.

Authors:  Philippa C Matthews; Christopher P Conlon; Anthony R Berendt; Jill Kayley; Lorrayne Jefferies; Bridget L Atkins; Ivor Byren
Journal:  J Antimicrob Chemother       Date:  2007-06-11       Impact factor: 5.790

10.  Stability of antibiotics in portable pumps used for bronchial superinfection: guidelines for prescribers.

Authors:  Nicolas Arlicot; Gaël Y Rochefort; Deborah Schlecht; Fabien Lamoureux; Sophie Marchand; Daniel Antier
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

View more
  5 in total

1.  Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps.

Authors:  L Saillen; L Arensdorff; E Moulin; R Voumard; C Cochet; N Boillat-Blanco; C Gardiol; S de Vallière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

Review 2.  Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Authors:  Ester Steffens; Charlotte Quintens; Inge Derdelinckx; Willy E Peetermans; Johan Van Eldere; Isabel Spriet; Annette Schuermans
Journal:  Infection       Date:  2018-11-15       Impact factor: 3.553

3.  OPAT in Switzerland: single-center experience of a model to treat complicated infections.

Authors:  Andrea Erba; Michelle Beuret; Mary-Louise Daly; Nina Khanna; Michael Osthoff
Journal:  Infection       Date:  2019-12-11       Impact factor: 3.553

4.  Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy.

Authors:  Jonathan Underwood; Michael Marks; Steve Collins; Sarah Logan; Gabriele Pollara
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

5.  Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.

Authors:  Haneen J Al Shareef; Adnan Al Harbi; Yasser Alatawi; Ahmed Aljabri; Mohammed A Al-Ghanmi; Mohammed S Alzahrani; Majed Ahmed Algarni; Attiah Khobrani; Abdul Haseeb; Faisal AlSenani; Mahmoud E Elrggal
Journal:  Antibiotics (Basel)       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.